How to do market research and why this is important? – Jan. 20, 2022

During this session our speakers will present and discuss how to perform market research for your invention, what to consider in the process of analyzing the market and what is the added value of understanding the target market and competitive advantage of your discovery, invention and technology. We will feature speakers from NSERC, IPO, and Lab2Market who can advise on the process. This session aims to stimulate commercial thinking during research and discovery phase.

The goal of PRiME's Jump Start series is to provide a deep dive into all steps in development of pre-clinical drugs, devices and platforms. We plan to invite experts who will discuss their views on the importance of each step. 

These workshops are open to all Trainees and Principal Investigators. 

PRESENTERS

Gary Svoboda
CEO, Adventus Research + Consulting Inc.
Gary Svoboda is Founder and CEO of Adventus Research + Consulting, a market research, strategy and management consultancy with offices in Guelph & Hamilton. His firm serves a wide range of clients with comprehensive market research/strategy and management consulting services. Gary has over 30 years of experience and has provided market research validation to hundreds of inventors, innovative companies and entrepreneurs launching new technologies, products and services. Prior to Adventus, he was a senior manager at the Canadian Innovation Centre in Waterloo. In addition to his market research experience, Gary Svoboda has served extensively as a corporate and industry spokesperson on the subject of invention, innovation and market research. Gary is a frequent conference presenter, and has appeared in over 100 print, radio and television spots over the past 20 years, including CBC Radio Noon, CBC News Channel, the Globe and Mail and the Toronto Star.

Wesley Kosiba
Learning and Recruitment Specialist, Lab2Market
As the Learning and Recruitment Specialist for Canada’s new research commercialization program —Lab2Market, Wesley supports some of Canada’s most promising researchers in assessing the commercial potential of their innovations. With over four years of experience in the field of innovation and entrepreneurship, as a founder, program developer, and administrator at Ryerson, Wesley has situated himself at the forefront of research commercialization programming. Wesley is an alumnus of Ryerson’s Master of Engineering Innovation and Entrepreneurship program and a Lean Startup and Customer Discovery lecturer.

Marilee Krinsky
Senior Commercialization Manager- Biomedical Life Sciences, Innovations and Partnerships, UofT

Marilee Krinsky is a Senior Commercialization Manager in the Innovations and Partnerships Office, Vice President Research and Innovation, at the University of Toronto. Marilee has over fifteen years of experience in managing the evaluation and commercialization of scientific research opportunities within academic, hospital, government and industrial settings. In her role at IPO, she manages the commercialization plans for a large portfolio of diverse biomedical and life science-based technologies including intellectual property protection, technology marketing and the negotiation of partnership and licensing agreements. Marilee has extensive experience in preparing IPO and NSERC market assessment "Idea to Innovation" grants. She has successfully raised funding for large-scale research projects and has fostered partnerships with industry stakeholders. She has also facilitated and supported the creation and strategic management of several UofT start-up companies. 

Rohan Alvares

Life Science Technology Analyst, UofT IPO
Rohan is a Life Science Technology Analyst at The Innovations & Partnerships Office (IPO) at the University of Toronto.  He has a PhD. in Chemistry from the University of Toronto and has recently transitioned into positions related to technology transfer.  At the IPO, he assists the Life Sciences team in the assessment of market and commercialization of emerging technologies.  Part of his work involves analysing and performing due diligence on technologies related to therapeutics, medical devices, and diagnostics, while also assisting marketing efforts.